logo

For the Inventor, By the Inventor

Emeryville, CA, United States of America

Chiron Corporation


USPTO Granted Patents = 672

% Expired Patents = 12.9


Trademarks = 11

Forward Citations = 20,520

Loading Chart...
Loading Chart...

597 inventors (with patents filed for the assignee):

goldMedal Michael Houghton (53 out of 110 patents)

silverMedal Michael S Urdea (51 out of 63 patents)

bronzeMedal George Kuo (32 out of 36 patents)

4.  Qui-Lim Choo (31 out of 42 patents)

5.  Ronald N Zuckermann (28 out of 42 patents)

6.  Thomas Horn (28 out of 35 patents)

7.  Philip J Barr (24 out of 67 patents)

8.  Robert F Halenbeck (24 out of 40 patents)

9.  Kirston E Koths (24 out of 44 patents)

10.  Pablo D Valenzuela (23 out of 27 patents)

11.  Guy T Mullenbach (22 out of 24 patents)

12.  David B Ring (21 out of 33 patents)

13.  Patricia A Tekamp-Olson (20 out of 22 patents)

14.  Brian David Warner (19 out of 38 patents)

15.  Steven Rosenberg (19 out of 37 patents)


Core Competencies:
Polypeptoid
Heterocyclic Compounds
GSK3 Polypeptides
Anticancer Agents
Therapeutic Polypeptides
Gene Products
Cytokine Administration
Inhibitors
Growth Factor
Gene Delivery
Peptide Ligands
Proteomic Analyses

672 patents:

1. 8673842 - Polypeptoid pulmonary surfactants (2014-03-18),
2. 8114830 - Polypeptoid pulmonary surfactants (2012-02-14),
3. 7705117 - EGFH2 genes and gene products (2010-04-27),
4. 7423148 - Small molecule PI 3-kinase inhibitors and methods of their use (2008-09-09),
5. 7368459 - Heterocyclic compounds (2008-05-06),
6. 7368453 - Quinazolinone compounds with reduced bioaccumulation (2008-05-06),
7. 7368106 - Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state (2008-05-06),
8. 7361484 - GSK3 polypeptides (2008-04-22),
9. 7345046 - Heteroaryl-fused pyrimidinyl compounds as anticancer agents (2008-03-18),
10. 7338935 - Chromatographic separation of therapeutic polypeptides (2008-03-04),
11. 7329741 - Polynucleotides that hybridize to DP-75 and their use (2008-02-12),
12. 7326711 - Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents (2008-02-05),
13. 7291725 - Sos1 inhibitors (2007-11-06),
14. 7285539 - Activation of HCV-specific T cells (2007-10-23),
15. 7279554 - Notch receptor ligands and uses thereof (2007-10-09),
Chiron Corporation is a pharmaceutical company specializing in research, development, and commercialization of innovative medical solutions. With a focus on biotechnology, Chiron aims to discover therapies that improve patient outcomes and quality of life. Our dedicated team of scientists, researchers, and healthcare professionals strive towards creating breakthrough treatments for various diseases and conditions. Visit our website to learn more about our portfolio of products, ongoing clinical trials, and commitment to advancing healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Chiron Corporation
672 Patents

#1 in Emeryville, CA

#170 in California

#742 in US

#1,474 in the World

Emeryville, CA (US)
Emeryville, CA, United States of America

Chiron Corporation

Forward Citations = 20,520

597 inventors:

goldMedal Michael Houghton (53 out of 110 patents)

silverMedal Michael S Urdea (51 out of 63 patents)

bronzeMedal George Kuo (32 out of 36 patents)

4.  Qui-Lim Choo (31 out of 42 patents)

5.  Ronald N Zuckermann (28 out of 42 patents)

Please report any incorrect information to [email protected]
Loading…